ACRS is currently covered by 7 analysts with an average potential upside of $14.16 (101.31%) backed by displayed 19 price targets and 36 ratings.
Analysts average stock forecasts to be materialized ratio is 21% with an average time for these price targets to be met of 101.3 days.
Highest price target for ACRS is 18, Lowest price target is 7, average price target is 12.5. For detailed individual stock analysts price targets on ACRS go to the chart section.
Most recent stock forecast was given by CORINNE JENKINS from GOLDMAN SACHS on 07-Mar-2023. First documented stock forecast 10-Jun-2016.
Currently, out of the existing stock ratings of ACRS - 13 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
21
$12.65 (151.50%)
25
2 months 25 days ago
0/2 (0%)
$11.37 (120.52%)
Buy
29
$20.65 (247.31%)
32
2 months 25 days ago
0/2 (0%)
$18.45 (191.49%)
Buy
50
$41.65 (498.80%)
3 months 8 days ago
0/2 (0%)
$25.37 (180.66%)
Buy
38
$29.65 (355.09%)
50
3 months 25 days ago
0/5 (0%)
$23.07 (116.66%)
Buy
29
$20.65 (247.31%)
5 months 18 days ago
0/1 (0%)
$12.83 (79.34%)
What is ACRS(Aclaris Therapeutics, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on ACRS(Aclaris Therapeutics, Inc) with a proven track record?
